[Analysis of Antimicrobial Resistance Trends and Characteristics of Vancomycin-resistant Enterococcus faecium Isolated in the Republic of Korea from 2018 to 2023]

[2018年至2023年韩国分离的耐万古霉素粪肠球菌的抗菌药物耐药性趋势及特征分析]

阅读:1

Abstract

Vancomycin-resistant enterococci (VRE) are a leading cause of healthcare-associated infections, with limited options for antimicrobial treatment. Resistance genes and their pathogenicity can be transmitted via transposons, making infection control crucial. In this study, we analyzed the antibiotic resistance trends and pathogenic characteristics of 179 Enterococcus faecium strains, which accounted for 78.5% of the 228 VRE strains collected from the epidemic intelligence division integrated system between 2018 and 2023. The analysis revealed that all strains were resistant to vancomycin, levofloxacin, and ciprofloxacin, but susceptible to linezolid and chloramphenicol. All 179 strains possessed the vanA gene. Among these, 55 strains (30.7%) exhibited the VanB phenotype and showed intermediate resistance or susceptibility to teicoplanin. As a result of virulence factor analysis, 155 strains (86.6%) were confirmed to possess both esp and hyl genes. Multilocus sequence typing analysis revealed ST17 (48.1%) and ST192 (11.1%) as the predominant sequence types, consistent with the global distribution patterns of vancomycin-resistant E. faecium (VREfm). This study provides critical insights into the antibiotic resistance trends and genetic characteristics of VREfm in the Republic of Korea, offering a foundation for antibiotic resistance prevention and infection control efforts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。